BioCatalyst

Modi-1 Moditope, Pembrolizumab, MicronJet600™ microneedle device (NanoPass) — catalyst calendar

1 verified catalyst event(s) referencing Modi-1 Moditope, Pembrolizumab, MicronJet600™ microneedle device (NanoPass), each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07-01
in 9d
ESTIMATED
 READOUT
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
Phase 1/2 · Triple Negative Breast Cancer, Renal Cell Cancer
 Scancell Ltd Modi-1 Moditope, Pembrolizumab, MicronJe ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.